Home The beneficial effect of psychological support on mothers with PKU children who suffer from social discrimination and damage of quality of life
Article
Licensed
Unlicensed Requires Authentication

The beneficial effect of psychological support on mothers with PKU children who suffer from social discrimination and damage of quality of life

  • Kostas Konstantinos Iakovou ORCID logo EMAIL logo and Kleopatra Schulpis
Published/Copyright: December 7, 2019

Abstract

Background

Phenylketonuria (PKU) is a metabolic disorder of phenylalanine (phe) metabolism caused by the liver enzyme phe hydroxylase deficiency resulting in mental retardation. The only treatment for this disorder is the lifelong restriction of natural protein supplemented with phe-free amino acid formula. The aim of this study was to demonstrate the beneficial effect of psychological support in relation to the educational status on mothers with PKU children, who suffered from social discrimination (SD) and damage of quality of life (QLD).

Methods

A total number of 42 mothers with PKU children with a mean age of 26.8 years took part in this study. According to their educational status, they were divided into three groups: group a, primary school (n = 13); group b, high school (n = 15) and group c, university degree (n = 14). Psychological support was given once per week for 1 year.

Results

University degree mothers achieved the best results in ameliorating their symptoms and signs. Mothers who had completed high school felt a moderate amelioration of their SD and QL, whereas those who had finished primary school only felt a mild reduction of their symptoms. Educational status of the affected mothers should be always taken into account for the classification of the affected mothers into therapeutic groups. Familial and professional environment are very important for the success of psychological support.

Conclusions

Overall, the psychological support related to symptoms and signs of this metabolic disorder is in comparison with that in diabetic patients.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Bhugra D. Social discrimination and social justice. Int Rev Psychiatry 2016;28:336–41.10.1080/09540261.2016.1210359Search in Google Scholar

2. Iakovou K, Madoglou A, Monopolis I, Schulpis K. The effect of PKU diet on the maternal quality of life and social discrimination in relation to their educational status and place of living. J Pediatr Endocrinol Metab 2019;32:281–5.10.1515/jpem-2018-0525Search in Google Scholar

3. Dominick KL, Ahern FM, Gold CH, Heller DA. Relationship of health-related quality of life to health care utilization and mortality among older adults. Aging Clin Exp Res 2002;14:499–508.10.1007/BF03327351Search in Google Scholar

4. DeSalvo KB, Bloser N, Reynolds K, He J, Muntner P. Mortality prediction with a single general self-rated health question. A meta-analysis. Gen Intern Med 2006;21:267–75.10.1111/j.1525-1497.2005.00291.xSearch in Google Scholar

5. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL). Development and psychometric properties. Soc Sci Med 1998;46:1569–85.10.1016/S0277-9536(98)00009-4Search in Google Scholar

6. Centers for Disease Control and Prevention. Measuring healthy days: population assessment of health-related quality of life. Atlanta, GA: Centers for Disease Control and Prevention; 2000.Search in Google Scholar

7. Selim AJ, Rogers W, Fleishman JA, Qian SX, Fincke BG, et al. Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12). Qual Life Res 2009;18:43–52.10.1007/s11136-008-9418-2Search in Google Scholar PubMed

8. Brumm VI, Bilder D, Waisbren SE. Psychiatric symptoms and disorders in phenylketonuria. Mol Genet Metab 2010;99:559–63.10.1016/j.ymgme.2009.10.182Search in Google Scholar PubMed

9. Phenylketonuria; PKU Online Mendelian Inheritance in Man® omim.org. http://www.omim.org/entry/261600 (last accessed 10-17-15).Search in Google Scholar

10. Manta-Vogli PD, Schulpis KH. Phenylketonuria dietary management and an emerging development. J Acad Nutr Diet 2018;118:1361–3.10.1016/j.jand.2017.05.020Search in Google Scholar PubMed

11. Schulpis KH, Karakonstantakis T, Bartzeliotou A, Karikas GA, Papassotiriou I. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet. ClinNutr 2004;23:401–7.10.1016/j.clnu.2003.09.006Search in Google Scholar PubMed

12. Iakovou K, Manta VP, Schulpis K. The effect of internet information on mothers with a newborn suspected for a chronic metabolic disease. Int J Health Sci 2018;6:53–5.Search in Google Scholar

13. Iakovou K, Shulpis K. Web medical information produces anxiety in parents of infants with suspected galactosemia. Rev Environ Health 2019;34:219–21.10.1515/reveh-2018-0064Search in Google Scholar PubMed

14. Iakovou K, Schulpis K. The significant role of educational status in PKU patients: the beneficial effect of psychological support in depression. Int J Adolesc Med Health 2019. DOI: 10.1515/ijamh-2018-0233 [Epub ahead of print].10.1515/ijamh-2018-0233Search in Google Scholar PubMed

15. Sanjay K, Biranchi NJ, Rajiv Y. Emotional and psychological needs of people with diabetes. Indian J Endocrinol Metab 2018;22:696–704.10.4103/ijem.IJEM_579_17Search in Google Scholar PubMed PubMed Central

16. Kalra S, Sridhar GR, Balhara YP, Sahay RK, Bantwal G, et al. National recommendations: psychosocial management of diabetes in India. Indian J Endocrinol Metab 2013;17:376–95.10.4103/2230-8210.111608Search in Google Scholar PubMed PubMed Central

17. Nicolucci A, Kovacs Burns K, Holt RI, Comaschi M, Hermanns N, et al. Diabetes attitudes, wishes and needs second study (DAWN2™): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med 2013;30:767–77.10.1111/dme.12245Search in Google Scholar PubMed

18. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM,et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000;23:934–42.10.2337/diacare.23.7.934Search in Google Scholar PubMed

19. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care 2004;27:1066–70.10.2337/diacare.27.5.1066Search in Google Scholar PubMed

20. Kokoszka A, Pouwer F, Jodko A, Radzio R, Mućko P, et al. Serious diabetes-specific emotional problems in patients with type 2 diabetes who have different levels of comorbid depression: a Polish study from the European depression in diabetes (EDID) research consortium. Eur Psychiatry 2009;24:425–30.10.1016/j.eurpsy.2009.04.002Search in Google Scholar PubMed

21. Shulpis K, Iakovou K. Replacement of breastfeeding with medical food for the treatment of galactosemia and phenylketonuria: maternal stress. J Pediatr Endocrinol Metab 2019;32:791–5.10.1515/jpem-2019-0109Search in Google Scholar PubMed

22. Iakovou K, Schulpis K. Phenylketonuric patients represent their disease. J Pediatr Endocrinol Metab 2019;32:1217–20.10.1515/jpem-2019-0253Search in Google Scholar PubMed

Received: 2019-08-20
Accepted: 2019-09-20
Published Online: 2019-12-07
Published in Print: 2020-01-28

©2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Inborn errors of metabolism
  4. Reviews
  5. Nutrition and medical support during pregnancy and lactation in women with inborn errors of intermediary metabolism disorders (IEMDs)
  6. The association between prenatal exposure to organochlorine compounds and neonatal thyroid hormone levels: a systematic review
  7. Original Articles
  8. Investigating the incidence rate and geographical distribution of congenital hypothyroidism among neonates in Isfahan province using geographic information system (GIS) between 2002 and 2015
  9. Analysis of five cases of hypermethioninemia diagnosed by neonatal screening
  10. What is the evidence for beneficial effects of growth hormone treatment beyond height in short children born small for gestational age? A review of published literature
  11. Machine learning-based prediction of response to growth hormone treatment in Turner syndrome: the LG Growth Study
  12. Pathogenic/likely pathogenic variants in the SHOX, GHR and IGFALS genes among Indian children with idiopathic short stature
  13. Celiac disease in Saudi children with isolated short stature: is it rare or are we not screening rigorously enough?
  14. The beneficial effect of psychological support on mothers with PKU children who suffer from social discrimination and damage of quality of life
  15. Long-term effects of GnRH agonist treatment on body mass index in girls with idiopathic central precocious puberty
  16. Sudden sex hormone withdrawal and the effects on body composition in late pubertal adolescents with gender dysphoria
  17. The alteration of IGF-1 levels and relationship between IGF-1 levels and growth velocity during GnRH analogue therapy
  18. BMI relationship to the onset of puberty: assessment of growth parameters and sexual maturity changes in Egyptian children and adolescents of both sexes
  19. The effects of a 12-week jump rope exercise program on body composition, insulin sensitivity, and academic self-efficacy in obese adolescent girls
  20. Onset of pituitary hormone deficiencies in optic nerve hypoplasia: a temporal trend analysis of 32 children at Mayo Clinic
  21. Dietary practices in methylmalonic acidaemia: a European survey
  22. Case Reports
  23. Clinical findings in five Turkish patients with citrin deficiency and identification of a novel mutation on SLC25A13
  24. A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation
  25. Sinusitis, an under-reported adverse effect in children treated with radioactive iodine therapy and review of the current literature
  26. Acknowledgment
Downloaded on 25.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0384/html
Scroll to top button